We Connect the worlds of Life Science Industry & Academia

We Connect the worlds of Life Science Industry & Academia



Since 2015 CamBioScience has provided intensive training courses in breakthrough life science technologies for professionals in academia and industry. To date this division of OBRIZUM Group Ltd. has trained an international customer base of professional scientists from over 60 leading academic and industrial institutions and more than 30 countries worldwide.



Dr Chibeza C. Agley

Chief Executive Officer

Dr. Chibeza Agley is a Research Fellow at the University of Cambridge and founded OBRIZUM Group Limited in 2015 with the specific aim of helping scientists to develop their commercial awareness and realise the economic value of their transferable skills. Dr. Agley grew the company from its origins as an interdisciplinary academic-to-industry consultancy service, to an international business supporting Biotech, Pharma and Healthcare industries worldwide. His current research at the University of Cambridge Stem Cell Institute amalgamates the fields of stem cell biology, physics and bioengineering. Chibeza continues to publish scientific papers and has received a number of notable academic awards for his research including the ‘Tadien Rideal Prize for Molecular Science’ in recognition of his PhD thesis. He maintains excellent local links with the Cambridge biotech cluster and the UK advertising industry and has developed long-standing global partnerships. As Chief Executive Officer of CamBioScience, Chibeza is focused on delivering innovative business solutions to our valued clients.

Dr Sarra Achouri

Chief Marketing Officer

Sarra is one of our three co-founders. She has been there from day 1 and has been building our brand ever since.  She holds a PhD in Physics from the Cavendish Laboratory and was a Next Generation Fellow at the Centre for Trophoblast Research, both at the University of Cambridge. Her scientific background is at the interface between physics and biology which equipped her with design, trouble shooting and cross discipline communication skills. Before starting OBRIZUM Group Limited, she also led the team that created the new art-meets-science event brand “Creative reactions” for  “Pint of Science”, the largest global science festival. Following a huge success on a shoe string budget, the Cambridge pilot experiment grew into a global brand and is now running yearly in 10 cities around the world.

Sarra leads the Marketing and branding efforts at OBRIZUM Group Limited, including its CamBioScience,  OBRIZUM®, and OBRIZUM Media divisions.

Science, Education, and Technology are the three pillars of our CMO’s vision for OBRIZUM Group Ltd. and our three divisions.




Dr Jürgen Fink

Chief Operating Officer
Juergen holds a PhD in Stem Cell Biology from the University of Cambridge.
As Chief Operating Officer of OBRIZUM Group Ltd., Juergen runs day-to-day operations, identifies needs for business optimisation and manages the successful implementation of new standard operating procedures for the group’s three divisions CamBioScience, OBRIZUM® and OBRIZUM Media. In his role as acting Chief Financial Officer, Juergen manages business accounts and internal budgets, overseas financial forecasts and reviews the business performance quarterly to ensure the growth of OBRIZUM Group Ltd.
Having gained professional experience in Germany, USA, South Korea and in the United Kingdom, Juergen is using his multidisciplinary and multicultural problem solving and communication skills to advance the international business development of CamBioScience. His experience and his keen eye for detail as well as his natural team leading and project management skills enable him to quickly adapt to projects in various fields and cultural environments. Entrepreneur minded, Juergen actively searches for profitable applications and for ways to commercialise his ideas.

Prof. Hugh Montgomery

Chairman of the board

Hugh Montgomery is a Professor of Intensive Care Medicine in London. He obtained a 1st class BSc in cardiorespiratory physiology and neuropharmacology in 1984, and his medical degree (MB.BS) from the University of London in 1987. He completed specialist training in General Internal Medicine, Cardiology and Intensive Care Medicine, and now practices as a consultant intensivist in North London. He obtained his higher research degree (MDRes) in 1997, and works at University College London as Professor of Intensive Care Medicine. He has authored over 350 scientific articles, two in Nature. His research interests have been broad: he reported the ‘first gene for human fitness’ and has worked on the human musculoskeletal, cardiac, inflammatory and metabolic responses to exercise; cardiac growth; mechanisms of human hypoxic adaptation; the skeletal muscle response to critical illness and more. Hugh is also an educator across media: he delivered the five televised Royal institution Christmas Lectures in 2007; has worked in radio; and has authored and edited diverse textbooks for undergraduates and postgraduates.

Zelmira Koch Polk

Non-Executive Director

Zelmira Koch Polk is a senior business executive with extensive experience building and turning around businesses internationally. She has worked in finance, crisis communications and management consulting with specialisation in the education and healthcare sectors. She has particular skills entering new geographic markets and adapting businesses to regulatory and cultural demands. Zelmira is a certified Dip Non Executive Director from the Institute of Directors and serves on the board of EdTech X Holdings, the world’s first publicly listed special purpose acquisition company focused on education, training and education technology. She also serves on the board of ARFA Röhrenwerke AG, a Swiss steel company and as board vice chair of Beavers School Hounslow. Zelmira is a founding partner of the Hearth Education Advisors, a global education advisory firm specialised in setting up education institutions and businesses internationally. Prior to the Hearth, Zelmira ran the international division of Chartwell Education Group, a leading American consulting group established by the former U.S. Secretary of education. Zelmira started her career in finance working at Credit Suisse First Boston and Dilenschneider Group, a leading crisis management and communication firm in New York.


Prof Stephen Harridge

SCIENTIFIC ADVISOR Physiology and Translational Biology BA, PhD

King’s College London

Dr Nick Hart

HEALTHCARE ADVISER Healthcare & Technology Development MB BS BSc PhD MRCP

Guy’s & St Thomas’ Hospitals

Dr Bon-Kyoung Koo

SCIENTIFIC ADVISER Organoid Technology & Genome Engineering

University of Cambridge

Prof. Han-Woong Lee


Yonsei University

Dr Mark Thomas

SCIENTIFIC ADVISER Computer Biology & Genome Analysis

Wellcome Trust Sanger Institute

Dr Barry Rosen

BIOPHARMA ADVISER Drug Discovery & Genome Engineering

Wellcome Trust Sanger Institute






CamBioScience Limited is registered in England, Scotland and Wales.
Registered Company Number: 9685974.
VAT Registration Number: GB 220165751

Registered Offices:
CamBioScience Ltd
Cambridge Eagle Lab
28 Chesterton Road


If you like what you see, please share it!Share on Facebook
Tweet about this on Twitter
Share on LinkedIn